The British Journal of Cancer (BJC) is one of the most cited general cancer journals, it is committed to publishing cutting edge discovery, translational and clinical cancer research. The BJC aims to provide a global platform to disseminate important research within the broad spectrum of oncology. The journal welcomes research across all cancer types and has a focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches.
British Journal of Cancer (BJC)
is :
International, Peer-Reviewed, Open Access, Refereed,
Biochemistry, Molecular Biology, Cancer Research, Oncology
,
Online
or
Print,
Semi-monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 0007-0920, E-ISSN - 1532-1827, Established in - 1947, Impact Factor - 9.1
True scholar network
